Charlie Stewart

Charlie Stewart is an associate in Goodwin’s Antitrust and Competition practice. He assists clients with addressing antitrust and competition issues related to merger reviews, compliance, government investigations, litigation, and other regulatory issues. He has significant experience in premerger counseling, including compliance with Hart-Scott-Rodino premerger requirements, and has also successfully guided clients through several investigations before the Antitrust Division of the United States Department of Justice and the Federal Trade Commission. Charlie has further assisted clients responding to litigation and internal investigations after allegations of anticompetitive conduct.

Charlie has represented clients in many industries, including life sciences, healthcare, technology, defense, aerospace, financial products and technology, and consumer goods.

Charlie is committed to pro bono service and represented clients in collaboration with the New England Innocence Project, California Innocence Project, Project Citizenship, and the Washington Legal Clinic for the Homeless.

Charlie’s recent representative experience includes:

• Forma Therapeutics in its acquisition by Novo Nordisk for $1.1 billion
• Nimbus Therapeutics in its sale of Allosteric Tyk2 Inhibitor Program to Takeda for $4 billion upfront and up to $6 billion total following antitrust litigation against Celgene and Bristol Myers Squibb to enjoin their attempted acquisition of the same program 
• Sichuan Kelun-Biotech Biopharmaceutical in its exclusive license and ADC collaboration agreement with Merck for $9.5 billion
• Owens Corning in its acquisition of WearDeck from JR Plastics Corporation*
• Parker Hannifin in its acquisition of Meggitt PLC for £6.3 billion*
• Monster Beverage in its acquisition of CANarchy Craft Brewery Collective LLC for $330 million*
• City of Hope in its acquisition of Cancer Treatment Centers of America*
• Procter & Gamble in its acquisition of TULA Life*
• The Duchossois Group in its sale of The Chamberlain Group LLC to Blackstone*
• Follett in its sale of Follett School Solutions to Francisco Partners*
• Cooper Tire & Rubber Company in its sale to The Goodyear Tire & Rubber Company for $2.5 billion*

*Denotes experience prior to joining Goodwin.